Shoreline Biosciences, Inc.

📍 La Jolla, United States🗓 Founded 2020👥 86 employees💰 Last funded 2021
Biotechnology Research🌐 shorelinebio.com
Website LinkedIn
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Shoreline Biosciences, Inc.?
Shoreline Biosciences, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Shoreline Biosciences, Inc. last raise funding?
The most recent investment in Shoreline Biosciences, Inc. recorded on gritt.io was in 2021.
When was Shoreline Biosciences, Inc. founded?
Shoreline Biosciences, Inc. was founded in 2020.
What industry is Shoreline Biosciences, Inc. in?
Shoreline Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Shoreline Biosciences, Inc. based?
Shoreline Biosciences, Inc. is headquartered in La Jolla, United States.